ODAIA is looking forward to taking part in the upcoming NEXT Normal Pharma Summit September event: "Digital Transformation in Pharma- the C-Suite perspective".
NEXT Normal is the ultimate event for CX, commercial excellence, marketing, and medical affairs leaders who want to design better engagement outcomes with HCPs and other stakeholders.
Speakers on this panel include masterminds from pharmaceuticals, digital health companies and tech companies. This includes Orchid Jahanshahi, Vice President of Lifescience at ODAIA and Jérôme de Larosière, Head of Marketing, Rare Diseases at IPSEN. An invitation for the registration can be found here.
ODAIA has innovated the first AI-powered Customer Data Platform (CDP) that pioneered the combination of process mining, customer journey mapping and AI to deliver goal-driven commercial insights and process automation as a SaaS.
ODAIA offers a self-serve platform: MAPTUAL, serving the biopharma industry.
The global pandemic has changed the customer-facing pharma business, forever. With direct access more difficult than ever, and HCP preferences shifting permanently toward digital engagement and personalized support, digital transformation is now a main priority.
ODAIA’s Trend Report highlights the key trends facing Pharma today to embrace AI.
A digital tool that makes next best action recommendations, identifies HCP receptiveness and targets effective omni-channel actions in order to achieve desired objectives.Our Solution
Watch our experts explain how MAPTUAL creates a unified experience with meaningful touchpoints
to better engage with your HCPs.